Kate Newbold

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Sung-Bae Kim, M. Schlumberger, M. Brose, 2015, The New England journal of medicine.

The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coils.

Christine Kong, Merina Ahmed, Kevin J Harrington, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy

Jung Hun Oh, Hiram Gay, Kevin Harrington, 2017, Clinical and translational radiation oncology.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Emma Hall, Kevin J Harrington, S. Bhide, 2011, The Lancet. Oncology.

A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer

Glenn D. Flux, Susan Buckley, Cecilia Hindorf, 2010, European Journal of Nuclear Medicine and Molecular Imaging.